Clinical Trials Logo

Ocular Inflammation clinical trials

View clinical trials related to Ocular Inflammation.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03408015 Withdrawn - Dry Eye Clinical Trials

Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease

Start date: January 2019
Phase: Phase 4
Study type: Interventional

Every night during sleep, there is an accumulation of white blood cells in the closed eye. The closed eye white blood cells are predominantly neutrophils, but there is a small population (3%) of T cells. The effects of these closed eye white blood cells on dry eye disease pathogenesis have yet to be fully elucidated, but preliminary evidence suggests that closed eye neutrophils may have an associated hyperactivity and increased degranulation in dry eye disease that could contribute to epithelial instability. As an anti-T cell therapy, Xiidra offers an opportunity to better understand how the closed eye white blood cells are recruited and activated. This study also seeks to verify the proposed mechanism of action.

NCT ID: NCT01721694 Withdrawn - Keratitis Clinical Trials

Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection

Start date: December 2012
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy and safety of fixed combination of azithromycin 1.5% + 0.5% Loteprednol eye drops for the treatment of ocular inflammation and infection associated bacterial blepharitis and / or keratitis and / or conjunctivitis compared with the individual administration of azithromycin 1.5% and 0.5% Loteprednol (separately).